Zhihui Amy Liu
Zhihui Amy Liu
Princess Margaret Cancer Centre, University Health Network
Verified email at uhnresearch.ca - Homepage
Title
Cited by
Cited by
Year
Safety, reliability and accuracy of small renal tumour biopsies: results from a multi‐institution registry
PO Richard, MAS Jewett, S Tanguay, O Saarela, ZA Liu, F Pouliot, ...
BJU international 119 (4), 543-549, 2017
542017
Pathological upstaging of clinical T1 to pathological T3a renal cell carcinoma: a multi-institutional analysis of short-term outcomes
JG Nayak, P Patel, O Saarela, Z Liu, A Kapoor, A Finelli, S Tanguay, ...
Urology 94, 154-160, 2016
482016
Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab
SV Bratman, SYC Yang, MAJ Iafolla, Z Liu, AR Hansen, PL Bedard, ...
Nature Cancer 1 (9), 873-881, 2020
472020
Factors influencing disease progression of prostate cancer under active surveillance: a McGill University Health Center cohort
GA Barayan, F Brimo, LR Bégin, JA Hanley, Z Liu, W Kassouf, ...
BJU international 114 (6b), E99-E104, 2014
442014
The natural history of renal function after surgical management of renal cell carcinoma: results from the Canadian Kidney Cancer Information System
R Mason, A Kapoor, Z Liu, O Saarela, S Tanguay, M Jewett, A Finelli, ...
Urologic Oncology: Seminars and Original Investigations 34 (11), 486. e1-486. e7, 2016
402016
Recovering the raw data behind a non-parametric survival curve
Z Liu, B Rich, JA Hanley
Systematic reviews 3 (1), 1-10, 2014
302014
Disease progression and kidney function after partial vs. radical nephrectomy for T1 renal cancer
CM Forbes, RA Rendon, A Finelli, A Kapoor, RB Moore, RH Breau, ...
Urologic Oncology: Seminars and Original Investigations 34 (11), 486. e17 …, 2016
282016
Positive surgical margins during partial nephrectomy for renal cell carcinoma: Results from Canadian Kidney Cancer information system (CKCis) collaborative
RK Bansal, S Tanguay, A Finelli, R Rendon, RB Moore, RH Breau, ...
Canadian Urological Association Journal 11 (6), 182, 2017
202017
Measuring the mortality impact of breast cancer screening
JA Hanley, M McGregor, Z Liu, EC Strumpf, N Dendukuri
Canadian Journal of Public Health 104 (7), e437-e442, 2013
182013
Clinical outcomes following laparoscopic management of pT3 renal masses: A large, multi-institutional cohort
JG Nayak, P Patel, J Bjazevic, Z Liu, O Saarela, A Kapoor, R Rendon, ...
Canadian Urological Association Journal 9 (11-12), 397, 2015
122015
EVOLVE: a multicenter open-label single-arm clinical and translational phase ii trial of cediranib plus olaparib for ovarian cancer after PARP inhibition progression
S Lheureux, A Oaknin, S Garg, JP Bruce, A Madariaga, NC Dhani, ...
Clinical Cancer Research 26 (16), 4206-4215, 2020
112020
A multicentered, propensity matched analysis comparing laparoscopic and open surgery for pT3a renal cell carcinoma
P Patel, JG Nayak, Z Liu, O Saarela, M Jewett, R Rendon, A Kapoor, ...
Journal of endourology 31 (7), 645-650, 2017
112017
A conditional approach to measure mortality reductions due to cancer screening
Z Liu, JA Hanley, O Saarela, N Dendukuri
International Statistical Review 83 (3), 493-510, 2015
112015
Evolve: A post PARP inhibitor clinical translational phase II trial of cediranib-olaparib in ovarian cancer—A Princess Margaret Consortium–GCIG Phase II Trial.
S Lheureux, A Oaknin, S Garg, J Bruce, NC Dhani, A Madariaga, L Bonilla, ...
Journal of Clinical Oncology 37 (15_suppl), 5521-5521, 2019
102019
Projecting the yearly mortality reductions due to a cancer screening programme
Z Liu, JA Hanley, EC Strumpf
Journal of medical screening 20 (3), 157-164, 2013
102013
Benchmarking quality for renal cancer surgery: Canadian Kidney Cancer information system (CKCis) perspective
KA Lawson, O Saarela, Z Liu, LT Lavallée, RH Breau, L Wood, ...
Canadian Urological Association Journal 11 (8), 232, 2017
82017
Surgical management of stage T1 renal tumours at Canadian academic centres
LT Lavallée, S Tanguay, MA Jewett, L Wood, A Kapoor, RA Rendon, ...
Canadian Urological Association Journal 9 (3-4), 99, 2015
82015
Rapid adaptation of breast radiation therapy use during the coronavirus disease 2019 pandemic at a large academic cancer center in Canada
CA Koch, G Lee, ZA Liu, FF Liu, A Fyles, K Han, A Barry, J Croke, D Rodin, ...
Advances in Radiation Oncology 5 (4), 749-756, 2020
7*2020
Bespoke circulating tumor DNA (ctDNA) analysis as a predictive biomarker in solid tumor patients (pts) treated with single-agent pembrolizumab (P).
MAJ Iafolla, C Yang, S Dashner, W Xu, AR Hansen, PL Bedard, ...
Journal of Clinical Oncology 37 (15_suppl), 2542-2542, 2019
62019
Rapid adaptation of breast radiation therapy use during the coronavirus disease 2019 pandemic at a large academic cancer center in Canada
CA Koch, G Lee, ZA Liu, FF Liu, A Fyles, K Han, A Barry, J Croke, D Rodin, ...
Advances in Radiation Oncology 5 (4), 749-756, 2020
52020
The system can't perform the operation now. Try again later.
Articles 1–20